Trial Profile
Multi-Center Study of Aflibercept Therapy for Neovascular Age-Related Macular Degeneration Using Treat and Extend Strategy
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 12 Jan 2015
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Age-related macular degeneration
- Focus Therapeutic Use
- 12 Jan 2015 New trial record